Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-29 @ 5:08 AM
Study NCT ID:
NCT04880850
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2021-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-06
First Submit QC Date:
None
Study First Post Date:
2021-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-15
Results First Submit QC Date:
None
Results First Post Date:
2025-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-06-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-11-27
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED